Home Other Building Blocks 2-Amino-5-ureidopentanoic acid

2-Amino-5-ureidopentanoic acid

CAS No.:
627-77-0
Catalog Number:
AG003GHT
Molecular Formula:
C6H13N3O3
Molecular Weight:
175.1857
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG003GHT
Chemical Name:
2-Amino-5-ureidopentanoic acid
CAS Number:
627-77-0
Molecular Formula:
C6H13N3O3
Molecular Weight:
175.1857
MDL Number:
MFCD00007955
IUPAC Name:
2-amino-5-(carbamoylamino)pentanoic acid
InChI:
InChI=1S/C6H13N3O3/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)
InChI Key:
RHGKLRLOHDJJDR-UHFFFAOYSA-N
SMILES:
NC(=O)NCCCC(C(=O)O)N
EC Number:
211-012-2
Properties
Complexity:
171  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
175.096g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
175.188g/mol
Monoisotopic Mass:
175.096g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
118A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
-4.3  
Literature
Title Journal
Genetics of rheumatoid arthritis: what have we learned? Immunogenetics 20110801
Year in review in Intensive Care Medicine 2010: II. Pneumonia and infections, cardiovascular and haemodynamics, organization, education, haematology, nutrition, ethics and miscellanea. Intensive care medicine 20110201
[Anticitrullin antibodies--modern markers of rheumatoid arthritis]. Terapevticheskii arkhiv 20110101
Developments in the scientific understanding of rheumatoid arthritis. Arthritis research & therapy 20090101
[The diagnostic accuracy of anti-citrullin antibody assessment in the diagnosis of patients suspected of rheumatoid arthritis by a general practitioner]. Nederlands tijdschrift voor geneeskunde 20080112
Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia. European journal of clinical investigation 20080101
Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis & tissue repair 20080101
METANNOGEN: compiling features of biochemical reactions needed for the reconstruction of metabolic networks. BMC systems biology 20070101
Nitric oxide and cardiovascular risk factors. Heart international 20070101
Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20051001
Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients. European journal of clinical investigation 20050101
[Comparative characteristics of specific autoantibodies in rheumatoid arthritis]. Terapevticheskii arkhiv 20050101
[Severe fulminant form of neonatal citrullinemia. Report of a case]. Revista de neurologia 20030401
Auto-protective redox buffering systems in stimulated macrophages. BMC immunology 20020101
Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients. BMC infectious diseases 20020101
Reactivity of two anti-galactosyl ceramide antibodies towards myelin basic protein. Journal of the neurological sciences 19920301
Properties